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We examined the molecular basis of virulence of pandemic H1N1/09 influenza viruses by reverse genetics based on two H1N1/09
virus isolates (A/California/04/2009 [CA04] and A/swine/Shandong/731/2009 [SD731]) with contrasting pathogenicities in mice.
We found that four amino acid mutations (P224S in the PA protein [PA-P224S], PB2-T588I, NA-V106I, and NS1-I123V) contrib-
uted to the lethal phenotype of SD731. In particular, the PA-P224S mutation when combined with PA-A70V in CA04 drastically
reduced the virus’s 50%mouse lethal dose (LD50), by almost 1,000-fold.
The outbreak of H1N1/09 influenza in North America in April2009 marked the global spread of the virus as the first pan-
demic of the 21st century (1, 2). Although most H1N1/09 infec-
tions were mild (1, 3), experts estimated that 284,500 people died
from the virus in the first 12 months of its circulation (4). Since
2009, strains of H1N1/09 influenza with differing virulences have
been observed in humans and animal models (5, 6). However, the
genetic basis of virulence of H1N1/09 viruses is not well under-
stood. Previously characterized molecular markers associated
with adaptation of influenza virus to humans, such as 627K in the
PB2 protein (PB2-627K), are not present in the H1N1/09 influ-
enza virus (7). Introduction of known virulence markers into the
H1N1/09 virus did not affect its pathogenicity (8, 9). A PB2-591K
residue was shown to compensate for the lack of PB2-627K in the
H1N1/09 virus (10). By serial passage of H1N1/09 virus in mice,
Zhou et al. found that the PB2-E158G mutation increased the
morbidity and mortality of H1N1/09 in mice (11). Ye et al. re-
ported that five amino acid substitutions distributed inHA, PA, or
NP protein from a mouse-adapted A/California/04/2009 (CA04)
virus contributed to the lethal phenotype in mice (12). The role
of the HA gene in the virulence of H1N1/09 viruses has also
been recognized in other studies (13, 14). Since mouse-adapted
H1N1/09 virulent strains are far removed from prevailing infec-
tions in natural hosts, in the present study, we identified natural
isolates of H1N1/09 influenza viruses in China that are more vir-
ulent in mice than an early representative isolate (CA04). The
virulence markers previously identified in H1N1/09 viruses are
absent in these isolates, indicating that they possess hitherto-un-
defined molecular determinants of pathogenicity.
Six natural occurring H1N1/09 viruses, including four swine iso-
lates and two human strains isolated in China, were identified in our
laboratory. A/Beijing/7/2009 and A/Beijing/132/2010 were isolated
from patients who exhibited influenza symptoms, including rhinor-
rhea, sneezing, coughing, and fever. Four swine H1N1/09 isolates
were isolated from diseased pigs characterized by coughing, fever,
abdominal respiration, and anorexia. These isolates, listed inTable 1,
were passaged twice inMDCK cells before they were sequenced. The
virulence of the six H1N1/09 strains in 6-week-old female BALB/c
mice was examined and compared with that of the early CA04 virus.
The 50% lethal dose (LD50) was determined for each isolate as previ-
ously described; mice that developed 25% body weight loss were
euthanized and classified as fatalities (15, 16). Thepathogenicity of all
six H1N1/09 isolates was greater than that of CA04 (Table 1). In
particular, the LD50 of A/swine/Shandong/731/2009 (SD731) virus
was more than 1,000-fold lower than that of CA04.
Subsequently, we examined the virulent SD731 and avirulent
CA04 viruses for molecular changes that would account for their
difference in virulence. Sequence comparison of their genomes
revealed 13 amino acid differences between SD731 and CA04,
located in the PB2, PA, HA, NP, NA, and NS genes (Fig. 1A). To
determine the role of each substitution in the virulence pheno-
type, we first generated six single-gene reassortant viruses by in-
troducing each individual gene from SD731 into the CA04 back-
bone by reverse genetics: CA04-SD731PB2, CA04-SD731PA,
CA04-SD731HA, CA04-SD731NP, CA04-SD731NA, and CA04-
SD731NS. Sequences of all reconstructed viruses were confirmed
by whole-genome sequencing. Five 6-week-old female BALB/c
mice were intranasally inoculated with 105 PFU of each virus and
were monitored for 14 days. SD731 genes displayed various con-
tributions to viral pathogenicity inmice (Fig. 1B). Introducing the
PA gene from SD731 alone caused fatality for all mice by 6 days
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TABLE 1 Virulence of pandemic H1N1 influenza viruses in mice
Virus name
LD50
(log10
PFU)
Residue at protein position
PB2-588 PA-70 PA-224 NA-106 NS1-123
A/California/04/2009 6.5 T A P V I
A/Beijing/7/2009 4.7 . . S I V
A/Beijing/132/2010 4.3 . . S I V
A/swine/Shandong/94/2010 4.5 . V S I V
A/swine/Shandong/361/2010 4.3 . V S I V
A/swine/Shandong/327/2010 4.3 . V S I V
A/swine/Shandong/731/2009 3.5 I V S I V
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postinoculation (dpi). Introducing the SD731 PB2, NA, or NS
gene individually resulted in somedeaths, while other reassortants
did not lead to mortality.
Since there was only one amino acid substitution for each re-
assortant carrying the SD731 PB2 (T588I), NA (V106I), or NS
(I123V) protein in the CA04 backbone, we propose that these
mutations are likely to be contributors to the increased virulence
of SD731. There are two amino acid differences in the PA protein
(PA carrying A70V [PA-A70V] and PA-P224S) between CA04
and SD731. To establish the relative contribution of each amino
acid substitution in PA to the virulence of SD731, we generated
separately recombinant viruses housing a PA-A70V or PA-P224S
mutation in the CA04 backbone [CA04-PA(A70V) and CA04-
PA(P224S), respectively]. CA04-PA(A70V) in mice had no effect
even at an inoculation dose of 106 PFU,whereas the LD50 ofCA04-
PA(P224S) was 104.3 PFU (Table 2). However, the pathogenicity
of CA04-PA(P224S) was still lower than that of CA04-SD731PA
(which contained both A70V and P224S and had an LD50 of 10
3.7
PFU). To determine if there was synergy between the two viral
polymerase subunits PA-P224S and PA-(A70V,P224S) with PB2-
T588I, we generated the CA04-PA(P224S)PB2(T588I) and CA04-
PA(A70V,P224S)PB2(T588I) viruses and evaluated their patho-
genicity in mice. We found that the pathogenicity of CA04
virus with mutations in both the PA and PB2 genes [CA04-
PA(P224S)PB2(T588I) and CA04-PA(A70V,P224S)PB2(T588I)]
was higher than that of the corresponding virus with a muta-
tion(s) in a single PA or PB2 gene and that the LD50 of CA04-
PA(A70V,P224S)PB2(T588I) was the same as that of wild-type
SD731 virus (LD50 10
3.5 PFU).
FIG 1 Relative pathogenicities of pandemic H1N1/09 influenza viruses with different amino acid mutations in mice. (A) Amino acid differences between the
avirulent CA04 and pathogenic SD731 viruses. (B) Survival percentages of mice infected with 105 PFU of each virus. (C) Photomicrographs of hematoxylin and
eosin (H&E)-stained lungs frommice infected with 104 PFU of virus at 6 dpi. Solid arrows, erosion of epithelial lining in the bronchioles; open arrow, extensive
epithelial damage and inflammatory cell infiltration in the bronchioles; triangle, alveolar interstitial consolidation and extensive inflammatory cell infiltration.
Magnification,100.
TABLE 2 Replication and pathogenicities of H1N1/09 viruses in mice
Virus
Titer of virus in lungs
(mean log10 PFU/gSD)
a
LD503 dpi 5 dpi
CA04 7.1 0.0 6.5 0.2 6.5
SD731 7.8 0.1 7.5 0.2 3.5
CA04-PA(A70V,P224S)PB2(T588I) 7.9 0.3 7.5 0.1 3.5
CA04-PA(P224S)PB2(T588I) 7.6 0.4 7.3 0.2 4.3
CA04-SD731PA(A70V,P224S) 7.8 0.2 7.4 0.2 3.7
CA04-SD731PB2(T588I) 7.5 0.1 6.8 0.4 5.5
CA04-PA(A70V) 7.0 0.2 6.6 0.2 6.5
CA04-PA(P224S) 7.7 0.1 7.2 0.2 4.7
CA04-SD731NA(V106I) 7.5 0.1 6.8 0.3 5.3
CA04-SD731NS(I123V) 7.7 0.4 7.3 0.3 5.7
a , P 0.05 compared with the value for CA04 virus (analysis of variance [ANOVA]);
, P 0.01 compared with the value for CA04 virus (ANOVA).
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The histopathology of lungs frommice, each inoculated with 104
PFU of H1N1/09 mutant virus, was examined at 5 dpi, as described
previously (17) (Fig. 1C). Lung sections from mice inoculated with
CA04 and CA04-PA(A70V) largely appeared normal. Moderate
bronchopneumonitis was found in the lungs of mice infected
withCA04-SD731PB2(T588I),CA04-SD731NA(V106I), andCA04-
SD731NS(I123V). These changes were characterized by epithelial
erosion in the bronchioles, interstitial edema, and extensive infiltra-
tion of inflammatory cells. Foci ofmore severe bronchopneumonitis
were observed in the lungs of mice infected with CA04-PA(P224S)
and CA04-PA(P224S)PB2(T588I) virus. Parent SD731, CA04-
SD731PA(A70V,P224S), and CA04-PA(A70V,P224S)PB2(T588I)
viruses induced themost severe bronchopneumonitis with extensive
alveolar damage.
To establish if the high pathogenicity of SD731 was associated
with enhanced virus replication, titers of virus in lung were deter-
mined for mice, each infected with 103 PFU of virus, at 3 and 5 dpi
(Table 2). The titers of SD731 were significantly higher than
those of CA04 at 3 and 5 dpi (P  0.05). The titers of CA04-
PA(A70V,P224S)PB2(T588I), CA04-PA(P224S)PB2(T588I), CA04-
SD731PA(A70V,P224S), CA04-PA(P224S), and CA04-SD731NS
(I123V) viruses were also significantly higher than those of CA04
virus at 3 and 5 dpi, while those of CA04-SD731PB2(T588I) and
CA04-SD731NA(V106I) were significantly higher than that of
CA04 at 3 dpi only (P 0.05).
Previous studies showed a positive correlation between the
polymerase activity of viral ribonucleoprotein (RNP) complex
and viral replication and pathogenicity (18, 19). To determine the
relative contributions of PA-A70V, PA-P224S, and PB2-T588I to
RNP polymerase activity, minigenome replication assays were
performed as previously described (17). RNP polymerase activity
of CA04 was significantly lower than those of the other mutants
(P 0.05) (Fig. 2). However, RNP activity of CA04 virus housing
the combined PA-A70V and PA-P224S mutations was signifi-
cantly greater than that with the single PA-P224S or PA-A70V
mutation (P  0.01). The RNP polymerase activity of CA04
with mutations in both the PA and PB2 genes [CA04-
PA(P224S)PB2(T588I) and CA04-PA(A70V,P224S)PB2(T588I)]
was significantly higher than corresponding RNP activity with a
mutation(s) in the single PA or PB2 gene (P 0.01).
To trace the evolutionary frequency of mutations identified in
this study, we analyzed all H1N1/09 viruses with full-length se-
quences available in the National Center for Biotechnology In-
formation Influenza Virus Resource (http://www.ncbi.nlm.nih
.gov/genomes/FLU/Database/nph-select.cgi?godatabase). The
frequency of viruses that possessed the naturalmutations reported
in the study had showed an upward trend over the past 4 years
(Table 3). The PB2-588I and PA-70V residues were absent in early
H1N1/09 strains. All reported PA-70V H1N1/09 viruses also car-
ried the PA-224S residue. Some early H1N1/09 strains possessed
proline at position PA-224; however, these viruses were rapidly
replaced by those with PA-224S. Since July 2009, all H1N1/09
isolates possessed serine at the PA-224 position, except for one
strain isolated in November 2009 and another isolated in Decem-
ber 2011. Frequencies of strains carrying NA-106I andNS1-123V,
present in less than half of the H1N1/09 strains in April 2009,
increased to more than 90% of the isolates in the latter half of
2009. These results suggest that viruseswith thesemutations could
have selective advantage in replication and/or transmission in hu-
mans.
In the present study, we found several mutations, not pre-
viously recognized, that contributed to the virulence of
H1N1/09 virus in mice. They include PB2-T588I, PA-P224S,
PA-A70V, NA-V106I, and NS1-I123V. The PB2-588 position is
located within the 627 domain and has been identified as a
host-range-specific amino acid position (20, 21); it is charac-
teristic of human influenza viruses, contributes to virus repli-
cation in mammalian cells, and partially compensates for the
lack of 627K (20, 21). The PA-P224S mutation is located in
the nuclear localization signal domain and may influence the
transport and accumulation of PA in the nuclei of virus-in-
fected cells (22). The PA-A70V mutation was identified in a
mouse-adapted H1N1/09 virus and on its own in CA04 back-
ground did not cause lethality or a more than 10% weight loss
(23), but we showed here that PA-A70V combined with PA-
P224S significantly boosted the lethality and lung pathology of
PA-P224S alone. The NA-V106I change was observed in
A/Mexico/4482/2009, one of the first H1N1/2009 viruses iso-
FIG 2 Polymerase activities of pandemic H1N1/09 influenza mutant vi-
ruses as determined by minigenome replication assays. Values shown are
the means SD of data from three independent experiments and are normal-
ized to those of SD731 (100%). #, the value for CA04 was significantly lower
than those for the other mutants (P  0.05 or P  0.01; analysis of variance
[ANOVA]); , the values of corresponding RNPs were significantly different
(P 0.01, ANOVA).
TABLE 3 Frequencies of amino acids in sequenced strains of pandemic H1N1/09 influenza virus
Amino acid
Frequency, % (na) for strains isolated in time period (mo/yr)
04/2009 05/2009 06/2009 07/2009 08/2009 09/2009 10/2009 11/2009 12/2009 2010 2011–2013
PB2-588I 0 (289) 0 (495) 0 (565) 0.7 (406) 2.2 (277) 0.8 (266) 2.3 (343) 5.3 (456) 2.3 (308) 4.8 (499) 5.6 (233)
PA-224S 98.4 (247) 99.3 (451) 99.8 (609) 100 (437) 100 (293) 100 (278) 100 (336) 99.8 (460) 100 (308) 100 (496) 99.6 (234)
PA-70V,224S 0 (247) 0 (451) 0.3 (609) 0.7 (437) 0 (293) 0.4 (278) 1.5 (336) 4.3 (460) 2.0 (308) 0.8 (497) 2.6 (234)
NA-106I 47.8 (345) 64.3 (504) 80.7 (670) 91.5 (611) 91.3 (413) 95.6 (476) 97.1 (581) 96.3 (725) 98.9 (435) 98.5 (970) 97.9 (946)
NS-123V 31.2 (295) 27.5 (509) 52.0 (658) 78.1 (494) 84.3 (300) 92.4 (314) 88.2 (390) 94.7 (489) 95.1 (326) 93.2 (573) 90.3 (268)
a Number of analyzed sequences is in parentheses.
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lated from a fatal human case (24). The NS1-I123V mutation is
located in the double-stranded RNA-dependent protein kinase
(PKR) binding site, which might enhance viral gene expression
(25). NS1-I123 is specific for cluster I and NS1-123V for cluster
II H1N1/09 viruses. Cluster I viruses appeared in early April
2009 and became extinct by the end of 2009, whereas cluster II
viruses emerged in late April 2009 and are in continuing circu-
lation (4).
The natural evolution of the current dominant virulence
mutations of H1N1/09 viruses reported in this study indicates
that they could not only confer a selective viral advantage in
humans but also are associated with virulence in mice. Contin-
uous surveillance and the timely evaluation of emergent viru-
lence determinants of H1N1/09 and other influenza viruses are
necessary for our preparedness to deal with future epidemics
and pandemics.
Nucleotide sequence accession numbers. Sequences for the
four swine isolates and two human strains identified in our labo-
ratory were submitted to GenBank under accession numbers
HQ533864, HQ533866, HQ533868, HQ533871, HQ533872,
HQ533874, HQ533877, HQ533879, JF951848 to JF951855,
JQ695860 to JQ695883, and KF918700 to KF918707.
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